Shire/Noven Resubmit ADHD Patch Application
Shire/Noven's resubmission for a methylphenidate transdermal system will receive a six month review at FDA, Shire said July 26
Shire/Noven's resubmission for a methylphenidate transdermal system will receive a six month review at FDA, Shire said July 26